STATUTORY RULES
1967 No.
_________
REGULATIONS UNDER THE NATIONAL HEALTH ACT 1953-1967.*
I, THE ADMINISTRATOR of the Government of the Commonwealth of Australia, acting with the advice of the Federal Executive Council, hereby make the following Regulations under the National Health Act 1953-1967.
Dated this twenty-sixth day of May, 1967.
EDRIC BASTYAN
Administrator.
By His Excellency’s Command,
(Signed) A. G. Forbes
Minister of State for Health.
_________
Amendments of the National Health (Pharmaceutical Benefits) regulations†
Commencement.
1. These Regulations shall come into operation on the first day of June, 1967.
First, Second, Third, Fourth and Fifth Schedules.
2. The First, Second, Third, Fourth and Fifth Schedules to the National Health (Pharmaceutical Benefits) Regulations arc repealed and the following Schedules inserted in their stead:—
FIRST SCHEDULE
Regulation 10.
Drugs and Medicinal Preparations in the British Pharmacopoeia that are not to be supplied as, or except as specially provided used in, pharmaceutical benefits
Acetomenaphthone. | Benztropine Methanesulphonate. |
Acetomenaphthone Tablets. | Betamethasone. |
Acetrizoic Acid. | Betamethasone Sodium Phosphate Tablets. |
Alcohol (95%). | Bisacodyl. |
Alcohol Dehydrated. | Bisacodyl Suppositories. |
Alcohols Dilute. | Bisacodyl Tablets. |
Almond Oil. | Busulphan. |
Amethocaine Hydrochloride. | Butobarbitone. |
Amitriptyline Hydrochloride. | Butylated Hydroxyanisole. |
Amitriptyline Injection. | Butylated Hydroxytoluene. |
Amodiaquine Hydrochloride. | Calciferol Solution. |
Amphetamine Sulphate. | Calcium Cyclamate. |
Amylobarbitone Sodium Tablets. | Caramiphen Hydrochloride. |
Anaesthetic Ether. | Caramiphen Tablets. |
Antazoline Hydrochloride. | Caraway. |
Antimony Potassium Tartrate. | Carbimazole. |
Antimony Potassium Tartrate Injection. | Carbon Dioxide. |
Antimony Sodium Tartrate. | Carbromal Tablets. |
Antimony Sodium Tartrate Injection. | Cardamom Fruit. |
Apomorphine Hydrochloride. | Cascara. |
Apomorphine Injection. | Catgut, Sterilised Surgical. |
Bacillus Calmette-Guérin Vaccine. | Cellulose, Oxidised. |
Bemegride. | Cetylpyridinium Chloride. |
Benzhexol Hydrochloride. | Chloral Betaine. |
* Notified in the Commonwealth Gazette on 1967.
† Statutory Rules 1960, No. 17, as amended by Statutory Rules 1960, Nos. 90 and 102; 1961, Nos. 59 and 137, 1962, Nos. 34, 101 and 114; 1963, Nos. 34, 69 and 107; 1964, Nos. 12, 57 and 135; 1965, Nos. 51, 151 and 152; and 1966, Nos. 80 and 144.
4281/67—Price 25c 10/18.5.1967
First Schedule—continued
Chlorambucil. | Diodone Injection. |
Chlordiazepoxide Capsules. | Diphtheria and Pertussis Vaccine. |
Chlordiazepoxide Hydrochloride. | Diphtheria, Tetanus and Poliomyelitis Vaccine. |
Chloroquine Phosphate. | Dipipanone Hydrochloride. |
Chloroquine Phosphate Injection. | Dipipanone Injection. |
Chloroquine Sulphate. | Dodecyl Gallate. |
Chlorothiazide. | Domiphen Bromide. |
Chlorphenesin. | Edrophonium Chloride. |
Chlorproguanil Hydrochloride. | Emetine and Bismuth Iodide. |
Chlorproguanil Tablets. | Emetine Hydrochloride. |
Chlorpropamide. | Erythromycin. |
Choline Theophyllinate. | Ethinyloestradiol. |
Choline Theophyllinate Tablets. | Ethisterone. |
Chorionic Gonadotrophin. | Ethopropazine Hydrochloride. |
Chorionic Gonadotrophin Injection. | Ethotoin. |
Cinchocaine Hydrochloride. | Ethyl Chloride. |
Cinnamon. | Ethyl Oleate. |
Citric Acid, Anhydrous. | Ethylenediamine Hydrate. |
Cochineal. | Eugenol. |
Codeine Compound Tablets. | Ferric Citrate (50Fe) Injection. |
Codeine Compound Soluble Tablets. | Fludrocortisone Acetate. |
Colchicine. | Fluocinolone Acetonide. |
Colchicum Corm. | Fluoxymesterone. |
Colchicum Liquid Extract. | Gallamine Triethiodide. |
Colistin Sulphate. | Gallamine Injection. |
Colistin Tablets. | Gelatin Sponge, Absorbable. |
Coriander. | Gentian. |
Corticotrophin. | Ginger. |
Cresol and Soap Solution. | Gold (108Au) Injection. |
Cresol. | Griseofulvin. |
Crotamiton. | Halothane. |
Cyanocabalamin. | Helium. |
Cyanocobalamin (57Co). | Heparin. |
Cyanocobalamin (58Co). | Hexamethonium Tartrate. |
Cyclamic Acid. | Hexamethonium Tartrate Injection. |
Cyclizine Tablets. | Hexylresorcinol. |
Cyclobarbitone Calcium. | Histamine Acid Phosphate. |
Cyclomethycaine Sulphate. | Histamine Acid Phosphate Injection. |
Cyclopropane. | Human Blood, Whole. |
Dapsone. | Human Red Blood, Corpuscles, Concentrated. |
Deoxycortone Trimethylacetate. | Human Fibrin Foam. |
Dequalinium Acetate. | Human Fibrinogen. |
Dequalinium Chloride. | Human Gamma Globulin. |
Dexamethasone. | Human Gamma Globulin Injection. |
Dexamethasone Acetate. | Human Plasma, Dried. |
Dexamphetamine Sulphate. | Human Serum, Dried. |
Dextran 110 Injection. | Human Thrombin. |
Dextromethorphan Hydrobromide. | Hydrallazine Hydrochloride. |
Dextromethorphan Tablets. | Hydrallazine Tablets. |
Dextropropoxyphene Capsules. | Hydrocortisone Ointment. |
Dextropropoxyphene Hydrochloride. | Hydrocortisone Acetate Ointment. |
Diamorphine Hydrochloride. | Hydrocortisone Hydrogen Succinate. |
Diamorphine Injection. | Hydrocortisone Sodium Succinate. |
Dibromopropamidine Isethionate. | Hydroflumethiazide. |
Dichloralphenazone. | Hydrogen Peroxide Solution, Strong. |
Dichlorophen. | Hydroxocobalamin. |
Dichlorphenamide. | Hydroxychloroquine Sulphate. |
Diethazine Hydrochloride. | Hyoscine Injection. |
Diethylcarbamazine Citrate. | Hyoscine Hydrobromide. |
Digitoxin. | Hyoscyamus. |
Diloxanide Furoate. | Imipramine Hydrochloride. |
Dimenhydrinate. | Indigo Carmine. |
Dimenhydrinate Injection. | Influenza Vaccine. |
Dimenhydrinate Tablets. | Iodinated (131I) Human Serum Albumin Injection. |
Dimercaprol. | Iodipamide Methylglucamine Injection. |
Dimethisterone. | Iodised Oil Fluid Injection. |
Dimethisterone Tablets. | Iodised Oil Viscous Injection. |
First Schedule—continued
Iopanoic Acid. | Novobiocin Sodium. |
Iopanoic Acid Tablets. | Nux Vomica. |
Iophendylate Injection. | Octyl Gallate. |
Iothalmic Acid. | Oestradiol Benzoate. |
Ipecacuanha, Prepared. | Opium. |
Ipecacuanha and Opium Tablets. | Opium, Powdered. |
Isoniazid. | Orange Peel, Dried Bitter. |
Isopropyl Alcohol. | Orange Peel, Fresh Bitter. |
Lead Acetate. | Oxygen. |
Lead Monoxide. | Oxyphencyclamine Hydrochloride. |
Lemon Peel, Dried. | Oxytetracycline Dihydrate. |
Levallorphan Injection. | Paramethadione. |
Levorphanol Tartrate. | Paromomycin Capsules. |
Lignocaine Hydrochloride. | Paromomycin Sulphate. |
Lignocaine and Adrenaline Injection. | Pempidine Tartrate. |
Lignocaine Hydrochloride Injection. | Pentamidine Isethionate. |
Liothyronine Sodium. | Pentamidine Injection. |
Lucanthone Hydrochloride. | Pentolinium Tartrate Tablets. |
Lucanthone Tablets. | Perphenazine. |
Magnesium Stearate. | Perphenazine Tablets. |
Maize Oil. | Pethidine Tablets. |
Male Fern. | Phanquone. |
Maleic Acid. | Phanquone Tablets. |
Measles Vaccine (Inactivated). | Phenacetin. |
Measles Vaccine (Live Attenuated). | Phenelzine Sulphate. |
Mecamylamine Hydrochloride. | Phenelzine Tablets. |
Meglumine Iothalamate Injection. | Phenglutarimide Hydrochloride. |
Melarsoprol. | Phenglutarimide Tablets. |
Menaphthone. | Phenindamine Tartrate. |
Menaphthone Sodium Bisulphite Injection. | Phenindione. |
Menaphthone Sodium Bisulphite. | Phenmetrazine Hydrochloride. |
Mepacrine Hydrochloride. | Phenmetrazine Tablets. |
Mephentermine Sulphate. | Phenolphthalein Tablets. |
Mephentermine Tablets. | Phenolsulphonphthalein. |
Meprobamate. | Phenoxybenzamine Hydrochloride. |
Meprobamate Tablets. | Phenoxymethylpenicillin. |
Mercaptopurine. | Phentolamine Hydrochloride. |
Mersalyl Acid. | Phentolamine Tablets. |
Metaraminol Tartrate. | Phentolamine Methanesulphonate. |
Methadone Hydrochloride. | Phentolamine Injection. |
Methandienone. | Phytomenadione. |
Methohexitone Injection. | Phytomenadione Capsules. |
Methoin. | Phytomenadione Tablets. |
Methyl Hydroxybenzoate. | Picrotoxin. |
Methylamphetamine Hydrochloride. | Picrotoxin Injection. |
Methyldopa. | Piperazine Citrate. |
Methylergometrine Maleate. | Piperocaine Hydrochloride. |
Methylthiouracil. | Poldine Methylsulphate. |
Methylthiouracil Tablets. | Poldine Tablets. |
Methyprylone. | Poliomyelitis Vaccine (Inactivated). |
Methyprylone Tablets. | Poliomyelitis Vaccine (Oral). |
Metronidazole. | Potassium Chloride Injection. |
Nalorphine Hydrobromide. | Potassium Perchlorate. |
Nandrolone Phenylpropionate. | Prednisolone Sodium Phosphate Injection |
Naphazoline Hydrochloride. | Prednisone. |
Neostigmine Bromide. | Prednisone Acetate. |
Nialamide. | Primaquine Phosphate. |
Nialamide Tablets. | Probenecid. |
Nicotinic Acid. | Procaine and Adrenaline Injection. |
Nikethamide. | Prochlorperazine Maleate. |
Nikethamide Injection. | Prochlorperazine Methanesulphonate. |
Nitrous Oxide. | Prochlorperazine Tablets. |
Norethandrolone. | Procyclidine Hydrochloride. |
Norethandrolone Tablets. | Progesterone. |
Norethisterone. | Proguanil Hydrochloride. |
Norethisterone Tablets. | Promazine Hydrochloride. |
Noscapine. | Promazine Injection. |
Novobiocin Calcium. | Promazine Tablets. |
First Schedule—continued
Promethazine Theoclate. | Sulphamethoxydiazine. |
Phomethazine Theoclate Tablets. | Sulphamethoxypyridazine. |
Pronethalol Hydrochloride. | Sulphapyridine. |
Pronethalol Injection. | Sulphasomidine. |
Phonethalol Tablets. | Sulphasomidine Tablets. |
Propyl Gallate. | Sulphinpyrazone. |
Propyl Hydroxybenzoate. | Sulphobromophthalein Sodium. |
Propyliodone. | Suramin. |
Propyliodone Injection. | Suramin Injection. |
Propyliodone Oily Injection. | Suxamethonium Chloride. |
Propylthiouracil. | Testosterone. |
Pyridostigmine Bromide. | Testosterone Phenylpropionate. |
Pyrimethamine. | Testosterone Phenylpropionate Injection. |
Pyrimethamine Tablets. | Testosterone Propionate. |
Quillaia. | Tetanus and Pertussis Vaccine. |
Rabies Antiserum. | Tetanus Vaccine (Alum Precipitated). |
Rabies Vaccine. | Tetanus Vaccine (Purified Toxoid Aluminimum Hydroxide). |
Santonin. | Tetanus Vaccine (Simple Solution). |
Senna Leaf. | Tetrachloroethylene. |
Sesame Oil. | Tetrachloroethylene Capsules. |
Soda Lime. | Thiambutosine. |
Sodium Acetriozoate Injection. | Thiomersal. |
Sodium Anoxynaphthonate. | Thiopentone Sodium. |
Sodium Antimonylgluconate. | Thiopentone Injection. |
Sodium Antimonylgluconate Injection. | Thioridazine Hydrochloride. |
Sodium Aurothiomalate. | Thyroid. |
Sodium Bicarbonate Compound Tablets. | Thyroxine Sodium. |
Sodium Bicarbonate Injection. | Tolazoline Hydrochloride. |
Sodium Calciumedetate. | Tolbutamide. |
Sodium Chromate (51Cr) Solution. | Tranylcypromine Sulphate. |
Sodium Citrate Tablets. | Tranylcypromine Tablets. |
Sodium Cyclamate. | Trichloroethylene. |
Sodium Diatrizoate. | Triclofos Sodium. |
Sodium Diatrizoate Injection. | Triclofos Tablets. |
Sodium Fluoride. | Tricyclamol Chloride. |
Sodium Fusidate Capsules. | Tripelennamine Hydrochloride. |
Sodium Iodide (181I) Injection. | Tryparsamide. |
Sodium Iodide (101I) Solution. | Tryparsamide Injection. |
Sodium Iothalamate Injection. | Tuberculin, Old. |
Sodium Lauryl Sulphate. | Tuberculin Purified Protein Derivative. |
Sodium Phosphate (32P) Injection. | Tubocurarine Chloride. |
Sodium Stibogluconate. | Tubocurarine Injection. |
Sodium Stibogluconate Injection. | Typhoid-Paratyphoid A and B and Cholera Vaccine. |
Solapsone. | Typhoid-Paratyphoid A and B and Tetanus Vaccine. |
Solapsone Tablets. | Typhoid-Paratyphoid A, B, and C Vaccine |
Spironolactone. | Undecenoic Acid. |
Staphylococcus Antitoxin. | Vancomycin Hydrochloride. |
Stibophen. | Vancomycin Injection. |
Stibophen Injection. | Vinyl Ether. |
Stramonium. | Vitamin A Ester Concentrate. |
Sulphadimethoxine. | Yellow Fever Vaccine. |
Sulphadimidine Sodium. | Zinc Undecenoate. |
Sulphamethizole. | Zinc Undecenoate Ointment. |
__________________________
SECOND SCHEDULE
Regulation 10 (3.).
Allowable Compounds (if any) of Certain Drugs or Medicinal Preparations
Pharmaceutical Benefits | Allowable Compounds (if any) |
Acetylcysteine................................. | — |
Acrylic Resin................................. | — |
Aluminium Powder, B.P.C......................... | Aluminium Powder B.P.C. with Liquid Paraffin B.P. and Zinc Oxide Ointment B.P. |
Amino Acids.................................. | Amino Acids with Sorbitol |
| Amino Acids with Sorbitol and Ethanol |
Amphotericin B................................ | Tetracycline with a buffering agent and Amphotericin B. |
Aneurine Hydrochloride, B.P........................ | Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D |
Antazoline Sulphate............................. | Antazoline Sulphate with Naphazoline Nitrate B.P. |
Ascorbic Acid, B.P.............................. | Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D |
Attapulgite................................... | Dihydrostreptomycin Sulphate B.P. 1958 with Attapulgite, Pectin and Hydrated Alumina Powder B.P. |
Bacitracin, B.P................................. | Polymyxin B Sulphate B.P. with Bacitracin B.P. and Neomycin Sulphate B.P. |
Betamethasone Sodium Phosphate, B.P................. | — |
Betamethasone Phosphate......................... | — |
Brompheniramine Maleate......................... | — |
Calciferol.................................... | — |
Carbachol, B.P................................. | — |
Carbinoxamine Maleate.......................... | — |
Carbromal, B.P................................. | Carbromal B.P., with Pentobarbitone Sodium B.P. |
Chloramine, B.P.C.............................. | — |
Chloramphenicol, B.P............................ | Chloramphenicol B.P. with Polymyxin B. Sulphate B.P. |
Chlorhexidine Gluconate.......................... | — |
Chlorpheniramine Maleate, B.P...................... | — |
Chlorpromazine Hydrochloride, B.P................... | — |
Chlortetracycline Hydrochloride, B.P.................. | — |
Clemizole Tannate.............................. | — |
Cortisone Acetate, B.P............................ | — |
Cymogran................................... | — |
Cyproheptadine Hydrochloride B.P.................... | — |
Cyclizine Hydrochloride, B.P....................... | Ergotamine Tartrate B.P. with Caffeine B.P. and Cyclizine Hydrochloride B.P. |
Demecarium Bromide............................ | — |
Demethylchlortetracycline Hydrochloride, B.P............ | Demethylchlortetracycline Hydrochloride B.P. with Nystatin B.P. |
Dexchlorpheniramine Maleate...................... | — |
Dextran..................................... | Dextran with Dextrose B.P. |
| Dextran in Normal Saline |
Dicyclomine Hydrochloride, B.P..................... | — |
Dienoestrol, B.P................................ | — |
Digoxin, B.P.................................. | — |
Dihydrostreptomycin Sulphate, B.P. 1958............... | Dihydrostreptomycin Sulphate B.P. 1958 with Attapulgite, Pectin and Hydrated Alumina Powder B.P. |
| Dihydrostreptomycin Sulphate B.P. 1958 with Kaolin, Pectin and Aluminium Hydroxide Gel |
Dihydrotachysterol.............................. | — |
Dimethicone.................................. | — |
Diphenhydramine Hydrochloride, B.P.................. | Ergotamine Tartrate B.P. with Caffeine Citrate B.P.C. 1959 and Diphenhydramine Hydrochloride B.P. |
Diphenylpyraline Hydrochloride..................... | — |
Diphtheria Vaccine, B.P........................... | Diphtheria Tetanus Vaccine B.P. Purified Toxoid (Aluminium Phosphate Adsorbed) B.P. |
| Diphtheria Tetanus Purified Toxoid (Aluminium Phosphate Adsorbed) and Pertussis Vaccine B.P. |
Second Schedule—continued
Pharmaceutical Benefits | Allowable Compounds (if any) |
Dyflos, B.P.C.................................. | — |
Ecothiopate Iodide.............................. | — |
Entsufon.................................... | Hexachlorophane B.P. with Entsufon |
Ergometrine Maleate............................ | Oxytocin with Ergometrine Maleate |
Ergotamine Tartrate, B.P.......................... | Ergotamine Tartrate B.P. with Caffeine B.P. |
| Ergotamine Tartrate B.P. with Caffeine B.P. and Cyclizine Hydrochloride B.P. |
| Ergotamine Tartrate B.P. with Caffeine Citrate B.P.C. 1959 and Diphenhydramine Hydrochloride B.P. |
| Ergotamine Tartrate B.P. with Caffeine B.P. and Meclozine Hydrochloride B.P. |
Erythromycin Oral Suspensions and Syrups............. | — |
Erythromycin Paediatric Drops...................... | — |
Ethosuximide................................. | — |
Ferric Hydroxide............................... | — |
Ferrous Aminoacetosulphate....................... | — |
Ferrous Succinate............................... | — |
Framycetin Sulphate............................. | — |
Fusidic Acid (Diethanolamine Salt)................... | — |
Galactomin, Formula No. 11....................... | — |
Glucose Indicator............................... | — |
Glyceryl Guiaiacolate............................ | Theophylline with Glyceryl Guaiacolate |
Gramicidin...................................
| Polymyxin B. Sulphate B.P. with Neomycin Sulphate B.P. and Gramicidin |
Hexachlorophane, B.P............................ | Hexachlorophane B.P. with Entsufon |
| Hexachlorophane B.P. with Lissapol |
| Hexachlorophane B.P. in Soap Solution |
Hydrocortisone, B.P............................. | — |
Hydrocortisone Acetate, B.P........................
| Hydrocortisone Acetate B.P. with Neomycin Sulphate B.P. |
Idoxuridine................................... | — |
Ipecacuanha, B.P................................
| Phenolphthalein B.P. with Aloin B.P.C., Dry Extract of Belladonna B.P., Strychnine B.P.C. 1959 and Ipecacuanha B.P. |
Isoprenaline Hydrochloride........................ | — |
Kanamycin Sulphate, B.P.C........................ | — |
Levallorphan Tartrate, B.P.........................
| Levallorphan Tartrate B.P. with Pethidine Hydrochloride B.P. |
Lissapol..................................... | Lissapol with Spearmint Oil B.P.C. and Cetrimide B.P. |
| Hexachlorophane B.P. with Lissapol |
Lofenalac.................................... | — |
Magnesium Chloride............................ |
Ammonium Chloride B.P. with Sodium Chloride B.P., Potassium Chloride B.P. and Magnesium Chloride |
| |
| Sodium Lactate with Potassium Chloride B.P., Magnesium Chloride and Sodium Chloride B.P. |
Mebhydrolin Napadisylate, B.P.C..................... | — |
Meclozine Hydrochloride, B.P.......................
| Ergotamine Tartrate B.P. with Caffeine B.P. and Meclozine Hydrochloride B.P. |
Mepyramine Maleate, B.P.......................... | — |
Methacycline................................. | — |
Methdilazine Hydrochloride........................ | — |
Methenamine Mandelate.......................... | — |
Methyl Glucamine.............................. | Theophylline B.P. with Methyl Glucamine |
Minafen..................................... | — |
Morphine Tartrate.............................. | Morphine Tartrate with Tacrine |
Naphazoline Nitrate, B.P.......................... | Naphazoline Nitrate B.P. with Antazoline Sulphate |
Neomycin Sulphate, B.P...........................
| Hydrocortisone Acetate B.P. with Neomycin Sulphate B.P. |
| Polymyxin B. Sulphate B.P. with Bacitracin B.P. and Neomycin Sulphate B.P. |
| Neomycin Sulphate B.P. with Kaolin B.P. |
| Polymyxin B. Sulphate B.P. with Neomycin Sulphate B.P. and Gramicidin |
Second Schedule—continued
Pharmaceutical Benefits | Allowable Compounds (if any) |
Neostigmine Methylsulphate, B.P.................. | — |
Nicotinamide, B.P............................ | Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D |
Nitrofurantoin, B.P............................ | — |
Nortriptyline Hydrochloride, B.P.................. | — |
Nystatin, B.P................................ | Tetracycline with a buffering agent and Nystatin B.P. |
| Oxytetracycline Hydrochloride B.P. with a buffering agent and Nystatin B.P. |
| Demethylchlortetracycline Hydrochloride B.P. with Nystatin B.P. |
Nutramigen................................ | — |
Oxytetracycline Hydrochloride, B.P................. | Oxytetracycline Hydrochloride B.P. with Polymyxin B. Sulphate B.P. |
| Oxytetracycline Hydrochloride B.P. with a buffering agent and Nystatin B.P. |
Oxytocin.................................. | Oxytocin with Ergometrine Maleate |
Pancreatin Enzyme, U.S.N.F. XI.................. | — |
Papaveretum, B.P.C........................... | Papaveretum B.P.C. with Hyoscine Hydrobromide B.P. |
Penicillin, Benethamine, B.P.C.................... | Penicillin, Benethamine B.P.C. with Procaine Penicillin B.P. and Sodium Penicillin B.P. |
Penicillin, Benzathine, B.P....................... | Penicillin, Benzathine B.P. with Procaine Penicillin B.P. and Potassium Penicillin B.P. |
Penicillin, Benzyl, B.P......................... | Penicillin, Benzyl B.P. with Streptomycin Sulphate B.P. |
| Fortified Procaine Penicillin Injection B.P. |
| Penicillin, Benzyl B.P. with Procaine Penicillin B.P. and Streptomycin Sulphate B.P. |
Penicillin, Phenoxymethyl (Benzathine, Calcium,....... Hydrabamine or Potassium Salt or Free Acid) | — |
Penicillin, Potassium, B.P....................... | Penicillin, Benzathine B.P. with Procaine Penicillin B.P. and Potassium Penicillin B.P. |
Penicillin, Procaine, B.P........................ | Penicillin, Benzathine B.P. with Procaine Penicillin B.P. and Potassium Penicillin B.P. |
| Fortified Procaine Penicillin Injection B.P. |
| Penicillin, Benethamine B.P.C. with Procaine Penicillin B.P. and Sodium Penicillin B.P. |
| Penicillin, Benzyl B.P. with Procaine Penicillin B.P. and Streptomycin Sulphate B.P. |
Penicillin, Sodium, B.P......................... | Penicillin, Benethamine B.P. with Procaine Penicillin B.P. and Sodium Penicillin B.P. |
Pertussis Vaccine, B.P......................... | Diphtheria, Tetanus Purified Toxoid (Aluminium Phosphate Adsorbed) and Pertussis Vaccine B.P. |
Pethidine Hydrochloride, B.P..................... | Pethidine Hydrochloride B.P. with Levallorphan Tartrate B.P. |
| Pethidine Hydrochloride B.P. with Scopolamine Hydrobromide B.P. |
Phenethicillin Potassium, B.P..................... | — |
Pheniramine Maleate.......................... | — |
Phenytain................................. | — |
Pilocarpine Hydrochloride...................... | — |
Pipenzolate Methobromide...................... | — |
Pituitary (Posterior Lobe), Powdered, B.P.C........... | — |
Polymyxin B. Sulphate, B.P...................... | Chloramphenicol B.P. with Polymyxin B. Sulphate B.P. |
| Oxytetracycline Hydrochloride B.P. with Polymyxin B. Sulphate B.P. |
| Polymyxin B. Sulphate B.P. with Bacitracin B.P. and Neomycin Sulphate B.P. |
| Polymyxin B. Sulphate B.P. with Neomycin Sulphate B.P. and Gramicidin |
| Polymyxin B. Sulphate B.P. with Propylene Glycol and Acetic acid |
Methylprednisolone, B.P........................ | — |
Second Schedule—continued
Pharmaceutical Benefits | Allowable Compounds (if any) |
Prednisolone Sodium Hemisulphate............. | — |
Prednisolone Sodium Phosphate, B.P............. | — |
Prednisolone Trimethylacetate, B.P.............. | — |
Primidone B.P............................ | — |
Promethazine Hydrochloride, B.P............... | — |
Riboflavine, B.P........................... | Vitamin A with Aneurine Hydrochloride B.P. Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D |
Senna Fruit, B.P........................... | — |
Silver Nitrate, Toughened, B.P................. | — |
Sobee................................. | — |
Sodium Aminosalicylate B.P................... | Sodium Aminosalicylate B.P. with Isoniazid B.P. |
Sodium Lactate........................... | Sodium Lactate with Potassium Chloride B.P. and Sodium Chloride B.P. |
| Sodium Lactate with Potassium Chloride B.P., Magnesium Chloride and Sodium Chloride B.P. |
| Sodium Lactate with Sodium Chloride B.P. and Dextrose B.P. |
| Sodium Lactate with Sodium Chloride B.P. |
| Sodium Lactate with Potassium Chloride B.P. and Dextrose B.P. |
Sodium Potassium Tartrate, B.P.C............... | Compound Effervescent Powder B.P.C. |
Sodium Tauroglycocholate, B.P.C. 1954.......... | Sodium Tauroglycocholate B.P.C. 1954 with Cascara Dry Extract B.P. |
Spearmint Oil, B.P.C........................ | Lissapol with Spearmint Oil B.P.C. and Cetrimide B.P. |
Strychnine, B.P.C. 1959..................... | Phenolphthalein with Aloin, Dry Extract of Belladonna, Strychnine B.P.C. 1959 and Ipecacuanha |
Sulphacetamide, B.P.C...................... | Sulphacetamide B.P.C. with Sulphamerazine B.P. 1958 and Sulphadiazine B.P. |
Sulphafurazole, B.P......................... | — |
Sulphamerazine, B.P. 1958................... | Sulphamerazine B.P. 1958 with Sulphadiazine B.P. and Sulphathiazole B.P.C. |
| Sulphamerazine B.P. 1958 with Sulphadiazine B.P. and Sulphacetamide B.P.C. |
| Sulphamerazine B.P. 1958 with Sulphadiazine B.P. and Sulphadimidine B.P. |
Sulphamethoxazole........................ | — |
Sulphaphenazole, B.P.C...................... | — |
Sulphathiazole, B.P.C....................... | Sulphathiazole B.P.C. with Sulphamerazine B.P. 1958 and Sulphadiazine B.P. |
Surgical Cement.......................... | — |
Surgical Cement Solvent..................... | — |
Tacrine................................ | Morphine Sulphate B.P. with Tacrine |
| Morphine Tartrate with Tacrine |
Tetanus Vaccine Purified Toxoid (Aluminium ......Phosphate Adsorbed) B.P. | Diphtheria and Tetanus Vaccine Purified Toxoid (Aluminium Phosphate Adsorbed) B.P. |
| Diphtheria, Tetanus and Pertussis Vaccine Purified Toxoid (Aluminium Phosphate Adsorbed) B.P. |
Tetracycline............................. | Tetracyline with a buffering agent |
| Tetracycline with a buffering agent and Amphotericin B. |
| Tetracycline with a buffering agent and Nystatin B.P. |
Thioridazine............................. | — |
Tragacanth, Indian (Gum Karaya)............... | — |
Trifluoperazine Hydrochloride, B.P.............. | — |
Trimeprazine Tartrate, B.P.C.................. | — |
Triprolidine Hydrochloride, B.P................ | — |
Vasopressin............................. | — |
Velactin................................ | — |
Viprynium Embonate, B.P.................... | — |
Vitamin A.............................. | Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D |
Vitamin D.............................. | Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D |
THIRD SCHEDULE
Regulation 11.
Drugs and Medicinal Preparations Additional to the Drugs and Medicinal Preparations in the British Pharmacopoeia
Acetazolamide Sodium. | Calcium Di-Oxytetracycline. |
Acetohexamide. | Calcium Gluconogalactogluconate. |
Acetylcysteine. | Calcium Phosphate, B.P.C. |
Acidified Golden Syrup, A.P.F. 1955. | Calumba, Concentrated Infusion, B.P. 1948 |
Acriflavine, B.P.C. | Calumba Tincture, B.P. 1948 |
Acrylic Resin. | Capsicum Ointment, B.P.C. |
Adrenaline Hydrochloride. | Capsicum Tincture, B.P.C. |
Adrenaline Mucate. | Carbamazepine. |
Agar, B.P.C. 1954. | Carbenoxolone Sodium. |
Aldosterone. | Carbinoxamine Maleate. |
Alkavervir. | Cardamom Aromatic Tincture, B.P.C. |
Allopurinol. | Catechu Tincture, B.P.C. |
Aloin, B.P.C. | Cephaloridine. |
Almond Oil Volatile Bitter, B.P.C. 1959. | Cetomacrogol Emulsifying Wax, B.P.C. |
Aloxidone. | Chloramine, B.P.C. |
Aluminium Acetate Solution, B.P.C. | Chloramphenicol Palmitate, B.P.C. |
Aluminium Hydroxide Mixture, A.P.F. | Chloramphenicol Stearate. |
Aluminium Sodium Polyhydroxy Monocarbonate Hexitol Complex. | Chloramphenicol Succinate. |
Aluminium Sodium Silicate. | Chlorazanil Hydrochloride. |
Aluminium Powder, B.P.C. | Chlorhexidine Diacetate. |
Amaranth Solution, A.P.F. | Chlorhexidine Gluconate. |
Amaranth Solution, Compound, A.P.F. | Chlorobenzol Disulphonamide. |
Amaranth Solution, B.P.C. | Chlorotrianisene, B.P.C. |
Amino Acids. | Chlorthalidone, B.P.C. |
Aminocaproic Acid. | Cholera El Tor Combined Vaccine. |
Ammonia Aromatic Spirit, B.P.C. | Cinnamon Spirit, B.P.C. 1949. |
Ammonia Solution Strong, B.P.C. | Cinnamon Water, Concentrated, B.P.C. |
Ammonium Bicarbonate. B.P.C. | Clemizole Hydrochloride. |
Ammonium Bromide, B.P.C. | Clemizole Tannate. |
Amphotericin B. | Clopamide. |
Angiotensin Amide. | Clove, Concentrated Infusion, B.P.C. 1954 |
Antazoline Methanesulphonate, B.P.C. | Coal Tar, B.P.C. |
Antazoline Sulphate. | Cochineal Tincture, B.P. 1948 |
Attapulgite. | Coconut Oil, B.P.C. 1949 |
Azathioprine. | Codeine, B.P.C. 1954 |
Beclamide. | Copper Sulphate, B.P.C. |
Beeswax, Yellow, B.P.C. | Creosote, B.P.C. 1959 |
Belladonna Suppository, B.P. 1948. | Cudbear Tincture, A.P.F. 1947 |
Benedict’s Solution, A.P.F. | Curd Soap, B.P.C. |
Benzalkonium Chloride. | Cyclopenthiazide. |
Benzoin, B.P.C. | Cyclothiazide. |
Benzoin Compound Tincture, B.P.C. | Cycrimine Hydrochloride. |
Benzoin Tincture, B.P.C. | Cymogran. |
Benzoinated Lard, B.P.C. 1954 | Death Adder Antivenene. |
Benzylpenicillin in Oil. | Demecarium Bromide |
Bephenium Hydroxynaphthoate, B.P.C. | Deoxycortone Glucoside. |
Betamethasone Phosphate. | Desferrioxamine. |
Bethanidine Sulphate. | Deslanoside. |
Biperiden Hydrochloride. | Dexamethasone Sodium Phosphate. |
Bismuth Subgallate, B.P.C. | Dexchlorpheniramine Maleate. |
Bretylium Tosylate. | Dextran. |
Brompheniramine Maleate. | Dextriferron. |
Brown Snake Antivenene. | Diazepam. |
Buchu Concentrated Infusion, B.P.C. 1954 | Digitalis Tincture, B.P.C. 1959 |
Butabarbital Sodium. | Dihydroergotamine Methanesulphonate. |
Butyl Aminobenzoate, B.P. 1953 | Dihydromorphinone Hydrochloride, B.P.C. 1949 |
Cade Oil, B.P.C. | Dihydrostreptomycin Sulphate, B.P. 1958. |
Caffeine and Sodium Benzoate, B.P.C. 1954 | Dihydrotachysterol. |
Caffeine Citrate, B.P.C. 1959. | Dimethicone, B.P.C. |
Cajuput Spirit, B.P. 1948 | Dimethindene Maleate. |
Calamine Cream Oily, A.P.F. | Diphenylpyraline Hydrochloride. |
Calcium Aurothiomalate. |
|
Third Schedule—continued
Dipyridamole. | Isopropramide Iodide. |
Disodium Stilboestrol Diphosphate. | Isothipendyl Hydrochloride, B.P.C. |
Dithiazanine Iodide | Kanamycin Sulphate, D.P.C. |
Dyflos, B.P.C. | Kitasamycin. |
Ecothiopate Iodide. | Lanatoside-C. |
Entsufon. | Lanette Wax SX. |
Ephedrine, B.P.C. | Lavender Spike Oil, B.P.C. |
Ergot, Liquid Extract, B.P. 1914. | Lemon Tincture, B.P. 1958. |
Erythrityl Tetranitrate. | Lincomycin Hydrochloride. |
Erythromycin Ethyl Succinate. | Lipopancreatin. |
Erythromycin Glucoheptonate. | Lissapol. |
Erythromycin Lactobionate. | Lobelia Ethereal Tincture, B.P.C. |
Ethacrynic Acid. | Lofenalac. |
Ethanolamine, B.P.C. | Lypressin. |
Ethanolamine Oleate. | Magenta, B.P.C. |
Ether Nitrous Spirit, B.P.C. 1959 | Magnesium-Aluminium Hydroxide. |
Ethionamide. | Magnesium Chloride. |
Ethoxzolamide. | Magnesium Hydroxide, B.P.C. |
Ethylidene Dicoumarin. | Mebhydrolin Napadisylate, B.P.C. |
Ethylnoradrenaline Hydrochloride. | Medroxyprogesterone Acetate. |
Ethyloestrenol. | Melphalan. |
Eucalyptol, B.P.C. | Mepenzolate Bromide. |
Ferric Hydroxide. | Mercaptomerin Sodium. |
Ferrous Aminoacetosulphate. | Mercuric Chloride, B.P.C. |
Ferrous Carbonate Saccharated, B.P.C. 1959 | Mestanolone. |
Ferrous Phosphate Compound Syrup, B.P.C. | Metaraminol Bitartrate. |
Ferrous Phosphate with Quinine and Strychnine Syrup, B.P.C. | Metformin Hydrochloride. |
Ferrous Succinate. | Methacycline. |
Fluorouracil Sodium. | Methaqualone Hydrochloride. |
Folinic Acid. | Methazolamide. |
Framycetin Sulphate. | Methdilazine Hydrochloride. |
Frusemide. | Methenamine Mandelate. |
Fusidic Acid, Diethanolamine Salt. | Methenolone Acetate. |
Galactomin, Formula No. 11. | Methotrexate. |
Gall and Opium Ointment, B.P.C. | Methoxamine Hydrochloride, B.P.C. |
Gelsemium Tincture, B.P.C. | Methsuximide. |
Glucagon Hydrochloride. | Methyclothiazide. |
Glucose Indicator. | Methyl Glucamine. |
Glycerophosphate Compound Syrup, A.P.F. | Methylphenobarbitone, B.P.C. |
Glyceryl Guaiacolate. | Methylprednisolone Acetate. |
Glycopyrronium Bromide. | Metyrapone. |
Glymidine. | Minafen. |
Goats Milk, dehydrated. | Morphine Tartrate. |
Gramicidin. | Myrrh Gum, Powdered, B.P.C. |
Hamamelis Liquid Extract, B.P.C. | Myrrh Tincture, B.P.C. |
Hexocyelium Methylsulphate. | Nalidixic Acid. |
Honey, Purified, B.P.C. | Nandrolone Decanoate. |
Hydrargaphen. | Natamycin. |
Hydrocyanic Acid, Dilute, B.P.C. 1954 | Niclosamide. |
Hydroxybenzoate Compound Powder, A.P.F. | Nicotinyl Alcohol Tartrate. |
Hydroxyprogesterone. | Nicoumalone. |
Hyoscine Methobromide. | Nitromin. |
Hypophosphorous Acid, Dilute, B.P.C. | Nux Vomica, Dry Extract, B.P.C. |
Idoxuridine. | Nutramigen. |
Indomethacin. | Octatropine Methylbromide. |
Insulin Injection, specially purified. | Oestradiol Diproprionate, B.P.C. 1954. |
Insulin Injection, Biphasic. | Oestrone, B.P.C. 1954. |
Insulin Injection, Neutral. | Oily Ophthalmic Vehicle, A.P.F. 1955. |
Insulin Isophane Injection, specially purified. | Orange Peel Compound, Concentrated Infusion, B.P.C. 1954. |
Insulin Injection, Special P (Pig). | Orange Peel, Concentrated Infusion, B.P.C. |
Iodochlorhydroxyquinoline. | Orciprenaline Sulphate. |
Iodoform, B.P.C. 1954 | Orphenadrine Hydrochloride. |
Iron Aminoates. | Oxycodone Pectinate. |
Iron Oxide Saccharated. | Oxymel, B.P.C. |
Iron Polymaltose Complex. | Oxymel of Squill, B.P.C. |
Iron Sorbitol Complex. | Oxymesterone. |
Isoprenaline Hydrochloride. | Oxyphenonium Bromide. |
Third Schedule—continued
Oxytetracycline. | Sodium Folate. |
Oxytocin. | Sodium Lactate. |
Pancreatin Enzyme, U.S.N.F. XI. | Sodium Nitrite, B.P.C. |
Papaveretum, B.P.C. | Sodium Potassium Tartrate, B.P.C. |
Papuan Black Snake Antivenene. | Sodium Tauroglycocholate, B.P.C. 1954. |
Para-Aminosalicylic Acid. | Sodium Thiosulphate. |
Paraben Ophthalmic Phosphate Buffer, A.P.F. 1955. | Spearmint Oil. B.P.C. |
Paraben Ophthalmic Vehicle, A.P.F. 1955. | Spiramycin. |
Paraffin Liquid Light, B.P.C. | Squill Tincture, B.P.C. |
Paramethasone Acetate. | Stanolone. |
Pargyline Hydrochloride. | Stanozolol. |
Pectin. | Stearic Acid, B.P.C. |
d-Penicillamine Hydrochloride, B.P.C. | Storax, Prepared, B.P.C. |
Penicillinase. | Strophantus Tincture, B.P. 1948. |
Penicillin, Benethamine, B.P.C. | Strychnine, B.P.C. 1959. |
Pentaerythritol Tetranitrate, diluted, B.P.C. | Sulphacetamide, B.P.C. |
Penthienate Methobromide. | Sulphadiazine Sodium, B.P.C. |
Peru Balsam, B.P.C. | Sulphaguanidine, B.P.C. |
Phenazone, B.P.C. | Sulphamerazine, B.P. 1958. |
Phenazopyridine Hydrochloride. | Sulphamethoxazole. |
Phenformin Hydrochloride. | Sulphaphenazole, B.P.C. |
Pheniramine Maleate. | Sulphasalazine. |
Pheniramine Para-Aminosalicylate. | Sulphathiazole, B.P.C. |
Phenol Ointment, B.P. 1948 | Sulphomyxin Sodium. |
Phenoxymethylpenicillin, Benzathine. | Sulphurated Potash, B.P.C. |
Phenoxymethylpenicillin, Hydrabamine. | Sulphuric Acid, Dilute, B.P.C. |
Phensuximide. | Sulphur Sublimed, B.P.C. |
Phenthimentonium. | Sultiame. |
Phenytoin. | Surgical Cement. |
Phthalylsulphacetamide. | Surgical Cement Solvent. |
Physostigmine, B.P.C. | Sustanon. |
Pilocarpine Hydrochloride. | Syrup Glucose Liquid, B.P.C. |
Pipenzolate Methobromide. | Tacrine. |
Pituitary Hormone, Follicle-stimulating. | Taipan Antivenene. |
Pituitary Hormone, Growth. | Tar Ointment. B.P.C. 1959. |
Pituitary (Posterior Lobe) Powdered, B.P.C. | Tartrazine, B.P.C. 1954. |
Polyoestradiol Phosphate. | Testosterone Oenanthate. |
Polythiazide. | Tetanus Immune Globulin (Human). |
Potable Water. | Tetracosactide. |
Potassium Chlorate, B.P.C. | Tetracycline. |
Potassium, Effervescent Tablets. | Theophylline Ethanoate of Piperazine. |
Prednisolone Sodium Hemisuccinate. | Thiethylperazine. |
Prednisolone Sodium Hemisulphate. | Thioridazine. |
Prednisolone Tertiary Butyl Acetate. | Thiotepa. |
Procarbazine Hydrochloride. | Thyrotrophin. |
Propranolol Hydrochloride. | Tiger Snake Antivenene. |
Protoveratrine A. | Titanium Dioxide, B.P.C. |
Pumilio Pine Oil, B.P.C. | Tolu Tincture, B.P.C. 1959. |
Pyrazinamide. | Tragacanth, Indian (Gum Karaya). |
Pyridine Aldoxime Methiodide. | Trasylol. |
Quillaia Tincture, B.P.C. | Tretamine. |
Quinethazone. | Triamcinolone, B.P.C. |
Quinidine Bisulphate. | Triamterene. |
Raspberry Syrup, B.P.C. | Tridihexethyl Chloride. |
Rauwolfia Alkaloids. | Triethanolamine, B.P.C. |
Red Back Spider Antivenene. | Trimeprazine Tartrate, B.P.C. |
Rolitetracycline. | Trinitrophenol, B.P.C. 1959. |
Rosemary Oil, B.P.C. | Trolnitrate Phosphate. |
Salicylamide. | Vadrine. |
Senega, Concentrated Infusion, B.P.C. | Valerian Ammoniated Tincture, B.P.C. |
Senna Compound Mixture, B.P.C. 1959 | Vanillin. |
Senna, Concentrated Infusion, B.P.C. 1959. | Vasopressin Tannate. |
Senna Fruit Extract (Standardised). | Velactin. |
Siberian Fir Oil. B.P.C. 1949 | Vinblastine Sulphate. |
Silver Protein, B.P.C. | Vincristine Sulphate. |
Silver Protein Mild, B.P.C. | Vinegar of Squill, B.P.C. |
Sobee. | Vitamin A. |
Sodium Carbonate Anhydrous, B.P.C. | Vitamin D. |
Sodium Edetate, B.P.C. |
|
FOURTH SCHEDULE
Regulation 12.
Additives
Acetone, B.P.C. | Ether Anaesthetic, B.P. |
Alcohol (95%), B.P. | Maize Oil, B.P. |
Dilute Alcohols, B.P. | Pilocarpine Hydrochloride |
Amethocaine Hydrochloride, B.P. | Sodium Thiosulphate B.P.C. |
Caraway Oil, B.P.C. | Solution of Burnt Sugar, B.P.C. 1959. |
Carmine Solution, A.P.F. | Xylene, B.P.C. 1949. |
Citronella Oil, B.P.C. |
|
FIFTH SCHEDULE
Regulation 14.
Pharmaceutical Benefits the Prescribing of Which is Subject to Conditions and Restrictions
Pharmaceutical Benefits..................... | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act | |
Acetylcysteine........................... | Fibrocystic Disease | |
Acetylsalicylic Acid Tablets, B.P............... |
| Any disease or condition in a pensioner |
Soluble Acetylsalicylic Acid Tablets B.P.......... | ||
Acetylsalicylic Acid with Paracetamol and Caffeine Tablets | ||
Acrylic Resin............................ | Ileostomy or colostomy conditions | |
Aldosterone............................. | With the written authority of the Director-General, treatment of an acute crisis in— | |
| Addison’s disease | |
| Salt-losing congenital adrenal hypoplasia | |
Allopurinol............................. |
| Any disease or condition in a patient receiving treatment in or at an approved hospital |
Aminocaproic Acid........................ | ||
Amino Acids............................ | ||
Amitriptyline Tablets, B.P.................... | Any disease or condition in a pensioner | |
| Any disease or condition in a patient receiving treatment in or at an approved hospital | |
| With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital | |
| The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride, Thioridazine Hydrochloride, Amitriptyline Hydrochloride, Imipramine Hydrochloride or Nortriptyline Hydrochloride | |
Amphetamine Sulphate Tablets, B.P............. | . | Any disease or condition in a pensioner |
Amphotericin B.......................... | Systemic fungal infection | |
Ampicillin Capsules, B.P..................... | With the written authority of the Director- General— | |
Ampicillin Injections, Tablets and Suspension | Gram-negative infections in pregnant women | |
Infections, in children under the age of five years, in which penicillin and sulphonamides are not effective | ||
Aneurine Hydrochloride Tablets, B.P | Any disease or condition in a pensioner | |
Angiotensin Amide........................ | Any disease or condition in a patient receiving treatment in or at an approved hospital | |
Fifth Schedule—continued
Pharmaceutical Benefits | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act | |
Ascorbic Acid Tablets, B.P..................... | Any disease or condition in a pensioner | |
Azathioprine.............................. |
| Any disease or condition in a patient receiving treatment in or at an approved hospital |
Beclamide................................ | ||
Betamethasone Tablets....................... | With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets | |
Betamethasone Sodium Phosphate Injection, B.P....... | Intra-articular use | |
Busulphan Tablets, B.P........................ | Leukaemia | |
|
| Any disease or condition in a pensioner |
Calciferol Tablets, B.P........................ | With the written authority of the Director-General— | |
Calciferol, B.P............................. | Hypoparathyroidism | |
| Chronic hypoparathyroid tetany | |
| Vitamin D-resistant rickets | |
Calcium Aminosalicylate...................... | Tuberculosis | |
Calcium Gluconogalactogluconate Effervescent Tablets.. | Hypoparathyroidism | |
Carbamazepine............................ | Epilepsy | |
....................................... | Trigeminal neuralgia | |
Carbenoxolone Sodium....................... |
| Any disease or condition in a patient receiving treatment in or at an approved hospital |
Cephaloridine............................. | ||
Chlorambucil Tablets, B.P...................... | Malignant lymphoma and related conditions | |
Chloramine Deodorant Tablets and Powder.......... | Ileostomy or colostomy conditions | |
Chloramphenicol Capsules, B.P.................. | Bacterial meningitis | |
| Haemophilus influenzae infections | |
| Intra-ocular infections | |
| Rickettsial infections | |
| Salmonella septicaemia | |
| Typhoid and paratyphoid | |
| Other serious infections sensitive only to Chloramphenicol | |
Chloramphenicol Injections.................... |
| A disease or condition specified in this column in relation to Chloramphenicol Capsules |
Chloramphenicol Tablets...................... | ||
Chloramphenicol Oral Suspension................ | ||
Chlorotrianisene Tablets...................... | Carcinoma of the prostate | |
Chloropromazine Hydrochloride................. | Any disease or condition in a pensioner | |
| Any disease or condition in a patient receiving treatment in or at an approved hospital | |
| With the written authority of the Director-General— | |
| Late-stage malignancy | |
| Radiation sickness | |
| Huntington’s chorea | |
| With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital | |
| The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride, Thioridazine Hydrochloride, Amitriptyline Hydrochloride, Imipramine Hydrochloride, or Nortriptyline Hydrochloride | |
Chlortetracycline Capsules, B.P.................. | Brucellosis | |
| Herpes zoster ophthalmicus | |
| Intestinal amoebiasis | |
| Leptospirosis | |
| Lymphogranuloma venereum | |
Fifth Schedule—continued
Pharmaceutical Benefits | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act | ||
Chlortetracycline Capsules B.P.—continued | Psittacosis | ||
Rickettsial infections | |||
| Any bacterial infections or actinomycosis or trachoma where these cannot be treated safely and effectively by sulphonamides or penicillins | ||
| Pre-operative and post-operative therapy where there are reasonable grounds for believing that infection may occur | ||
Chlortetracycline Hydrochloride Granules | A disease or condition specified in this column in relation to Chlortetracycline Capsules | ||
Cloxacillin Sodium, B.P....................... |
| Any disease or condition in a patient receiving treatment in or at an approved hospital | |
Cloxacillin Capsules. B.P...................... | |||
Codeine Phosphate with Acetylsalicylic Acid Soluble Tablets |
| Any disease or condition in a pensioner | |
Codeine Phosphate with Acetylsalicylic Acid Tablets | |||
Codeine Phosphate with Acetylsalicylic Acid and Paracetamol soluble Tablets | |||
Codeine Phosphate with Acetylsalicylic Acid, Paracetamol and Caffeine Tablets | |||
Cod Liver Oil Emulsion....................... | Any disease or condition in a child under the age of twelve years or in a pensioner | ||
Colistin Sulphomethate Injection, B.P. | Pyocyaneus infection and Gram-negative infections where no other drug is effective | ||
Corticotrophin Injection, B.P. |
| With the written authority of the Director-General— | |
Corticotrophin Gelatin Injection, B.P. | A disease or condition specified in this column in relation to Cortisone Injection | ||
Corticotrophin Zinc Hydroxide Injection, B.P. | |||
Hypsarrhythmia | |||
Salaam convulsions | |||
The prevention of side effects of corticosteroid therapy | |||
Cortisone Injection, B.P....................... | With the written authority of the Director-General— | ||
| Acute exophthalmic ophthalmoplegia | ||
| Acute heart block complicating myocardial infarction | ||
| Anaemia, acquired haemolytic | ||
| Addison’s disease | ||
| Adrenocortical hypoplasia | ||
| Adrenalectomy, total | ||
| Adrenogenital syndrome | ||
| Agranulocytosis | ||
| Behcet’s syndrome | ||
| Cerebral tumours and cerebral oedema | ||
| Cranial arteritis | ||
| Cushing’s syndrome, including hyperadrenocorticalism | ||
| Dermatitis, acute exfoliative | ||
| Dermatomyositis | ||
| Encephalomyelitis | ||
| Encephalomyelitis, acute disseminated | ||
| Guillain-Barré syndrome | ||
| Hamman-Rich syndrome—diffuse interstitial pulmonary fibrosis | ||
| Hansen’s disease | ||
| Hepatitis, progressive or continuing, proven by biopsy Or biochemistry | ||
| Hodgkin’s disease | ||
| Idiopathic hypercalcaemia | ||
| Inflammatory conditions of the uveal tract and retina | ||
| Interstitial Keratitis due to syphilis or vernal conjunctivitis | ||
| Keratoplasty | ||
| Leucine-sensitive hypoglycaemia | ||
Fifth Schedule—continued
Pharmaceutical Benefits | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act | |
Cortisone Injection, B.P.—continued | Leukaemia | |
| Lymphosarcoma and follicular lymphoma | |
| Metastatic breast cancer | |
| Mycosis fungoides | |
| Nephrosis or nephrotic syndrome | |
| Neuromyelitis optica | |
| Opticneuritis following removal of tumor of the brain | |
| Panhypopituitarism | |
| Pemphigus | |
| Periarteritis nodosa | |
| Progressive transverse myelitis | |
| Pseudohermaphroditism | |
| Purpura, Henoch’s | |
| Purpura, thrombocytopenic | |
| Regional ileitis (Crohn’s disease) | |
| Recticulum cell sarcoma | |
| Rheumatic carditis, acute | |
| Sarcoidosis | |
| Scleroderma | |
| Severe reactions of the skin and mucosa following X-ray therapy | |
| Splenic neutropenia | |
| Status asthmaticus | |
| Steroid therapy prior to operation in patients under steroid therapy | |
| Stevens-Johnson syndrome | |
| Still’s disease in a child under the age of sixteen years | |
| Sympathetic ophthalmitis | |
| Systemic lupus erythematosus | |
| Temporal arteritis | |
| Treatment of malignancy in conjunction with radiotherapy or chemotherapy | |
| Tropical and non-tropical sprue and all forms of malabsorption associated with those diseases | |
| Type II Nephritis | |
| Ulcerative colitis proven by sigmoidscopy or radiological report | |
Cortisone Tablets, B.P........................ | With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection | |
|
| Established megalocytic anaemia |
Cyanocobalamin Injection, B.P................... | Neuroblastoma | |
| Subacute combined degeneration of the cord | |
Cymogran................................ | With the written authority of the Director-General, phenylketonuria | |
Cycloserine Tablets, B.P....................... |
| Any disease or condition in a patient receiving treatment in or at an approved hospital |
Cycloserine Capsules, B.P...................... | ||
Demethylchlortetracycline Capsules, B.P |
| A disease or condition specified in this column in relation to Chlortetracycline Capsules, except herpes zoster ophthalmicus |
Demethylchlortetracycline Hydrochloride Oral Paediatric Drops and Oral Suspension | ||
Demethylchlortetracycline Hydrochloride with Nystatin | Any disease or condition specified in this column in relation to Oxytetracycline Hydrochloride with a buffering agent and Nystatin | |
Deodorant Detergent Solution (Lissapol with Spearmint Oil and Cetrimide) | Ileostomy or colostomy conditions | |
Deoxycortone Aqueous Injections |
| Addison’s disease Adrenalectomy, total |
Deoxycortone Acetate Injection, B.P. | ||
Deoxycortone Trimethylacetate Injection, B.P. | ||
Deoxycortone Acetate Implants, B.P. | ||
Deoxycortone Acetate Tablets................... | ||
Fifth Schedule—continued
Pharmaceutical Benefits | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act | |
Desferrioxamine............................ | Any disease or condition in a patient receiving treatment in or at an approved hospital | |
Dexamethasone Tablets, B.P.................... | With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets | |
Dexamethasone Sodium Phosphate Injections | Intra-articular use | |
Dexamphetamine Tablets, B.P................... | Any disease or condition in a pensioner | |
Diazepam Injection, Syrup and 10 mg. tablet | Any disease or condition in a patient receiving treatment in or at an approved hospital | |
Diazepam Tablets 2 mg. and 5 mg. | Treatment in multiple sclerosis | |
Dienoestrol Cream.......................... | Any disease or condition in a pensioner | |
Dienoestrol Tablets, B.P....................... | Carcinoma of the prostate | |
| Mammary carcinoma | |
| Any disease or condition in a pensioner | |
Dihydrostreptomycin Sulphate Injection | As an alternative to Streptomycin Sulphate in the case of a person who is being treated for a disease or condition specified in this column in relation to Streptomycin Sulphate and who is allergic to Streptomycin Sulphate | |
Dihydrotachysterol.......................... | Parathyroid deficiency | |
Diloxanide Furoate Tablets, B.P.................. | Amoebic dysentery | |
Dimethicone.............................. | Ileostomy or colostomy conditions | |
Disodium Stilboestrol Diphosphate............... | Carcinoma of the prostate | |
Dithiazanine Iodide | Infestations of Trichuris trichiura or Strongyloides stercoralis | |
Ditophal................................. | Any disease or condition in a patient receiving treatment in or at an approved hospital | |
Erythromycin.............................. | Brucellosis | |
| Intestinal amoebiasis | |
| Leptospirosis | |
| Lymphogranuloma venereum | |
| Mycoplasma pneumoniae (Eaton’s Agent) | |
| Psittacosis | |
| Rickettsial infections | |
| Staphylococcal septicaemia or staphylococcal pneumonia | |
| Any bacterial infections or spirochaetal infection or actinomycosis or trachoma where these cannot be treated safely and effectively by sulphonamides or penicillins | |
| Pre-operative and post-operative therapy where there are reasonable grounds for believing that infection may occur | |
Ethinyloestradiol Tablets, B.P................... | Any disease or Condition in a pensioner | |
| Hereditary telangiectasis | |
| Pre-menopausal castration syndrome | |
| Turner’s syndrome | |
Ethionamide.............................. | Tuberculosis | |
Ethisterone Tablets, B.P....................... | Turner’s syndrome | |
Ethyloestrenol............................. | With the written authority of the Director-General, intermittent use for corticosteroid-induced osteoporosis | |
Fludrocortisone Tablets, B.P.................... | Addison’s disease | |
| Adrenocortical hypoplasia | |
| Total adrenalectomy | |
Fluorouracil Sodium......................... | Carcinoma of the colon and rectum | |
Fluoxymesterone Tablets, B.P................... | Castration syndrome (male) | |
| Mammary carcinoma | |
| With the written authority of the Director-General, intermittent use for corticosteroid-induced osteoporosis | |
Folic Acid Injection......................... |
| Macrocytic anaemia |
Folic Acid Tablets, B.P........................ | Sprue or the spruc-like syndrome | |
Folinic Acid.............................. | Any disease or condition in a patient receiving treatment in or at an approved hospital | |
Framycetin Sulphate Tablets.................... | Bowel sterilization preparatory to major surgery | |
Fusidic Acid (Sodium Salt or Diethanolamine Salt) | With the written authority of the Director-General, infections where positive bacteriological evidence confirms that Fusidic Acid (Sodium Salt or Diethanolamine Salt) is the only appropriate antibiotic | |
Fifth Schedule—continued
Pharmaceutical Benefits | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act | |
Galactomin Formula No. 11.................... | With the written authority of the Director-General— | |
| Galactosaemia | |
| Conditions needing an extreme restriction of lactose in the patient’s diet, in children under the age of four years | |
Goats Milk, dehydrated....................... | With the written authority of the Director-General, cows milk allergy in children under the age of four years | |
Griseofulvin Tablets, B.P...................... | With the written authority of the Director-General, for use in severe tinea infections due to Microsporum, Trichophyton or Epidermophyton species which have been proven by laboratory examination | |
Halibut Liver Oil Capsules..................... | Any disease or condition in a pensioner | |
Hexachlorophane with Entsufon................. |
| Any disease or condition in a patient receiving treatment in or at an approved hospital |
Hexachlorophane with Lissapol.................. | ||
Hexachlorophane in Soap Solution................ | ||
Hydrocortisone Injection...................... | With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection | |
Hydrocortisone Acetate Injection, B.P. | Intra-articular use | |
Hydrocortisone Sodium Succinate Injection | Acute adrenal failure due to medical or surgical crises | |
Prophylaxis of adrenal insufficiency during and after major surgery for patients already on steroid therapy | ||
| Stevens-Johnson syndrome | |
|
| Established megalocytic anaemia |
Hydroxocobalamin Injection, B.P. | Neuroblastoma | |
| Sub-acute combined degeneration of the cord | |
|
| Endometrial carcinoma |
Hydroxyprogesterone........................ | Habitual abortion | |
| Progesterone deficiency proven by hormonal assay of lateral wall smear | |
Idoxuridine............................... | Infections caused by Herpes Simplex Virus | |
Imipramine Tablets, B.P....................... | Any disease or condition in a pensioner | |
| Any disease or condition in a patient receiving treatment in or at an approved hospital | |
| With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital | |
| The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride, Thioridazine Hydrochloride, Amitriptyline Hydrochloride, Imipramine Hydrochloride or Nortriptyline Hydrochloride | |
Indomethacin Capsule............................ | Rheumatoid arthritis or osteroarthritis not responding to salicylates | |
| Acute attacks of gout | |
Isoniazid Tablets, B.P............................. | Tuberculosis | |
Kanamycin Sulphate Capsules, Injections and Oral Solution | With the written authority of the Director-General, infections where positive bacteriological evidence confirms that Kanamycin Sulphate is the only appropriate antibiotic | |
Kitasamycin................................... | Any disease or condition in a patient receiving treatment in or at an approved hospital | |
Levorphanol Tartrate............................. | Obstetrical use | |
| Severe intractable pain | |
Lincomycin Hydrochloride......................... | Osteomyelitis | |
| Pneumococcal Meningitis | |
Liothyronine Tablets, B.P.......................... | Myxoedema | |
| Myxoedema coma | |
Fifth Schedule—continued
Pharmaceutical Benefits | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act | ||||
Lipopancreatin............................. | Any disease or condition in a patient receiving treatment in or at an approved hospital | ||||
Lofenalac................................ | With the written authority of the Director-General, phenylketonuria | ||||
Medroxyprogesterone Acetate Tablets | Endometrial carcinoma | ||||
Medroxyprogesterone Acetate Injections | Endometrial carcinoma | ||||
Progesterone deficiency proven by hormonal assay of lateral wall smear | |||||
| |||||
Melphalan................................ | Malignant melanoma | ||||
| Multiple myeloma | ||||
Mercaptopurine Tablets, B.P.................... | Allergic angiitis | ||||
| Leukaemia | ||||
| Lupus erythematosus | ||||
| Periarteritis | ||||
Mestanolone.............................. | Mammary carcinoma | ||||
| With the written authority of the Director-General, intermittent use for corticosteroid-induced osteoporosis | ||||
Methacycline.............................. | A disease or condition specified in this column in relation to Chlortetracycline Capsules, except herpes zoster ophthalmicus | ||||
Methandienone Tablets, B.P.................... |
| With the written authority of the Director-General, intermittent use for corticosteroid-induced osteoporosis | |||
Methenolone Acetate......................... | |||||
Methicillin Sodium.......................... |
| Any disease or condition in a patient receiving treatment in or at an approved hospital | |||
Methicillin Injection, B.P...................... | |||||
Methotrexate Tablets......................... | Leukaemia and neoplastic disease | ||||
Methotrexate Injections....................... | Any disease or condition in a patient receiving treatment in or at an approved hospital | ||||
Methylamphetamine Injection, B.P................ |
| Any disease or condition in a pensioner | |||
Methylamphetamine Tablets, B.P................. | |||||
Metyrapone............................... | Any disease or condition in a patient receiving treatment in or at an approved hospital | ||||
Minafen.................................
| With the written authority of the Director-General, phenyl ketonuria | ||||
Morphine Sulphate, B.P. with Tacrine Tablets | Severe intractable pain | ||||
| |||||
Mustine Hydrochloride Injection................. | Malignant lymphoma and related conditions | ||||
Nalidixic Acid............................. | With the written authority of the Director-General, urinary tract infections | ||||
Nandrolone Phenylpropionate Injection, B.P.......... |
| With the written authority of the Director-General, intermittent use for corticosteroid-induced osteoporosis | |||
Nandrolone Decanoate....................... | Mammary carcinoma | ||||
| With the written authority of the Director-General, intermittent use for corticosteroid-induced osteoporosis | ||||
Neomycin Tablets, B.P........................ | Bowel sterilization preparatory to major surgery | ||||
| Portal-systematic encephalopathy | ||||
Nicotinic Acid Tablets, B.P..................... | Any disease or condition in a pensioner | ||||
Nitrofurantoin Tablets, B.P..................... |
| Urinary tract infections | |||
Nitrofurantoin Oral Suspension.................. | |||||
Nitromin................................. | Malignant lymphoma and related conditions | ||||
|
| Any disease or condition in a pensioner | |||
| Any disease or condition in a patient receiving treatment in or at an approved hospital | ||||
| |||||
| With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital | ||||
Nortriptyline Hydrochloride, B.P. | |||||
Nortriptyline Tablets, B.P...................... | |||||
Nortriptyline Capsules, B.P..................... | |||||
| |||||
The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further | |||||
Fifth Schedule—continued
Pharmaceutical Benefits | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act | |||||
Nortriptyline Hydrochloride, B.P. |
| treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride, Thiordazine Hydrochloride, Amitriptyline Hydrochloride, Imipramine Hydrochloride or Nortriptyline Hydrochloride | ||||
Nortriptyline Tablets, B.P...................... | ||||||
Nortriptyline Capsules, B.P.—continued | ||||||
Nutramigen............................... | With the written authority of the Director-General— | |||||
| Cows milk allergy in children under the age of four years | |||||
| Galactosaemia | |||||
| Lactose intolerance | |||||
| Fibrocystic disease of the pancreas in children under the age of four years | |||||
Nystatin Tablets, B.P......................... | Monilia infections | |||||
Orciprenaline Sulphate Injection................. |
| Any disease or condition in a patient receiving treatment in or at an approved hospital | ||||
Orciprenaline Sulphate Solution for Inhalation | ||||||
Oxycodone Pectinate......................... | Late-stage malignancy | |||||
Oxymesterone............................. | With the written authority of the Director-General, intermittent use for corticosteroid-induced osteoporosis | |||||
Oxytetracycline Hydrochloride Capsules |
|
| ||||
Oxytetracycline Tablets, B.P.................... | A disease or condition specified in this column in relation to Chlortetracycline Capsules except herpes zoster ophthalmicus | |||||
Oxytetracycline Injections..................... | ||||||
Calcium di-Oxytetracycline Oral Suspension | ||||||
Calcium di-Oxytetracycline Paediatric Drops |
| |||||
Oxytetracycline Hydrochloride with a buffering agent and Nystatin |
| Broad spectrum antibiotic therapy of premature infants, of patients under steroid therapy or of cases complicated by intestinal moniliasis | ||||
A second or repeated course of broad spectrum antibiotic therapy for a disease or condition specified in this column in relation to Chlortetracycline Capsules except herpes zoster ophthalmicus | ||||||
Pancreatin, B.P............................. |
| Fibrocystic disease | ||||
Pancreatico-duodenectomy | ||||||
Pancreatin Enzyme U.S.N.F. XI................. | Pancreatic steatorrhoea | |||||
Para-Aminosalicylic Acid..................... | Tuberculosis | |||||
Paracetamol Suspension....................... |
| Any disease or condition in a pensioner | ||||
Paracetamol Tablets, B.P....................... | ||||||
Paracetamol with Codeine Phosphate and Pentobarbitone Sodium | Any disease or condition in a pensioner | |||||
Paramethasone Acetate....................... | With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection | |||||
Paraffin Liquid Emulsion...................... |
| Any disease or condition in a pensioner | ||||
Paraffin Liquid Emulsion with Phenolphthalein | ||||||
Pargyline Hydrochloride...................... | Any disease or condition in a patient receiving treatment in or at an approved hospital | |||||
Penicillamine.............................. | With the written authority of the Director-General— | |||||
| Cystinosis | |||||
| Cystinuria with calculus formation | |||||
| Treatment of cold agglutinin haemoglobinuria | |||||
| Acute heavy metal intoxication | |||||
| Wilson’s Disease (hepatolenticular degeneration) | |||||
Penicillin Benzathine Tablets and Capsules |
| Prevention of recurrent streptococcal infections, including rheumatic fever | ||||
Penicillin Benzyl Tablets, B.P................... | ||||||
Penicillin Benzyl Capsules..................... |
| |||||
Benzylpenicillin injection 5,000,000 units and 10,000,000 units | Bacterial endocarditis or septicaemia | |||||
Benzylpenicillin with Streptomycin Sulphate |
|
| ||||
Benzylpenicillin with Procaine Penicillin and Streptomycin Sulphate | Endocarditis due to Streptococcus faccalis or Streptococcus viridans | |||||
Fifth Schedule—continued
Pharmaceutical Benefits | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act | |||
Pethidine Hydrochloride with Levallorphan Tartrate | Obstetrical use | |||
Phenylbutazone Tablets B.P..................... |
| Acute attacks of gout | ||
Phenylbutazone Capsules...................... | Osteoarthritis or Rheumatoid Arthritis not responding to salicylates | |||
Phytomenadione Injection, B.P................... | Antidote to anticoagulants | |||
Pituitary, Posterior Lobe, Insufflation | Diabetes insipidus | |||
Polymyxin B. Sulphate Injection................. | Any disease or condition in a patient receiving treatment in or at an approved hospital | |||
Polyoestradiol Phosphate...................... | Carcinoma of the prostate | |||
Prednisolone Sodium Phosphate Retention Enema and Suppository | With the written authority of the Director-General— | |||
Ulcerative colitis proven by sigmoidoscopy or radiological report | ||||
| Proctitis proven by sigmoidoscopy | |||
Prednisolone Tablets, B.P...................... | With the written authority of the Director-General— | |||
| Cerebral oedema; Cerebral tumors; Acute exophthalmic ophthalmoplegia; Interstitial keratitis due to syphilis or vernal conjunctivitis; Malignancy treatment in conjunction with radiotherapy or chemotherapy; Acute heart block complicating myocardial infarction | |||
| Nodular non-suppurative panniculitis (Christian-Weber disease) | |||
| A disease or condition specified in this column in relation to Cortisone Injection except total adrenalectomy, Addison’s disease or adrenocortical hypoplasia | |||
Prednisolone Acetate Injection.................. |
|
| ||
Prednisolone Methyl Acetate Injections |
| |||
Prednisolone Tertiary Butyl Acetate Injections | Intra-articular use | |||
Prednisolone Trimethylacetate Injections |
| |||
Methylprednisolone Tablets, B.P. |
| With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets. | ||
Methylprednisolone Capsules................... | ||||
Prednisolone Sodium Hemisuccinate | Prophylaxis of adrenal insufficiency during and after major surgery for patients already on steroid therapy | |||
| With the written authority of the Director-General, medical or surgical crises | |||
Prednisone Tablets, B.P....................... | With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets | |||
Procarbazine Hydrochloride.................... | Any disease or condition in a patient receiving treatment in or at an approved hospital | |||
|
| Habitual abortion | ||
Progesterone.............................. | Progesterone deficiency proven by hormonal assay of lateral wall smear | |||
Propranolol Hydrochloride..................... |
| Any disease or condition in a patient receiving treatment in or at an approved hospital | ||
Pyrazinamide.............................. | ||||
Pyridostigmine Injection, B.P.................... |
|
| ||
Pyridostigmine Tablets, B.P..................... | Myasthenia gravis | |||
Pyridoxine Hydrochloride Tablets | Peripheral neuritis due to isoniazid therapy | |||
| Radiation sickness | |||
Quinine Bisulphate Tablets, B.P.................. |
|
| ||
Quinine Dihydrochloride Tablets................. |
| |||
Quinine Hydrochloride Tablets.................. | Malaria | |||
Quinine Sulphate Tablets, B.P................... |
| |||
Riboflavine Tablets.......................... |
|
| ||
Senna Fruit Extract (Standardised) Sobee........... | Any disease or condition in a pensioner | |||
| With the written authority of the Director-General— | |||
| Galactosaemia | |||
| Lactose intolerance | |||
| Milk allergy in children under the age of four years | |||
Fifth Schedule—continued
Pharmaceutical Benefits | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act | |||
Sodium Aminosalicylate Tablets, B.P. |
|
| ||
Sodium Aminosalicylate Injection |
| |||
Sodium Aminosalicylate Cachets | Tuberculosis | |||
Sodium Aminosalicylate Granules |
| |||
Sodium Aminosalicylate with Isoniazid B.P. |
| |||
Sodium Folate............................. | Macrocytic anaemia | |||
| Sprue or the sprue-like syndrome | |||
Spiramycin............................... | Serologically proven active toxoplasmosis | |||
| Staphylococcal septicaemia or staphylococcal pneumonia | |||
| Any gram-positive bacterial infections where these cannot be treated safely and effectively by sulphonamides or penicillins | |||
Spironolactone Tablets, B.P..................... | With the written authority of the Director-General, to supplement other diuretics when these have proved inadequate | |||
Stanolone................................ | Mammary carcinoma | |||
| With the written authority of the Director-General, intermittent use for corticosteroid-induced osteoporosis | |||
Stanozolol................................ | With the written authority of the Director-General, intermittent use for corticosteroid-induced osteoporosis | |||
|
| Carcinoma of the prostate | ||
Stilboestrol Injection......................... | Mammary carcinoma | |||
Stilboestrol Tablets, B.P....................... | Any disease or condition in a pensioner | |||
| Heriditary Telangiectasis | |||
Streptomycin Sulphate Injections................. | Bacillary dysentery that is resistant to the Sulphonamides | |||
| Brucellosis | |||
| Chancroid | |||
| Endocarditis due to Streptococcus faecalis or Streptococcus viridans | |||
| Friedlander bacillus infections | |||
| Haemophilus influenzae infections | |||
| Plague | |||
| Pseudomonas pyocyanea infections | |||
| Rat-bite fever (Streptobacillus moniliformis) | |||
| Salmonella infections | |||
| Surgical conditions of the bowel (pre-operative and postoperative) | |||
| Surgical conditions of the thoracic organs | |||
| Tuberculosis | |||
| Tularaemia | |||
| Urinary tract infections that are resistant to the Sulphonamides | |||
Sulphasalazine............................. | Ulcerative colitis | |||
Sulphomyxin Sodium........................ | Any disease or condition in a patient receiving treatment in or at an approved hospital | |||
Sultiame................................. | For use where other anticonvulsants have failed | |||
Surgical Cement............................ |
| Ileostomy or colostomy conditions | ||
Surgical Cement Solvent...................... | ||||
Sustanon................................. |
|
| ||
Testosterone Implants, B.P..................... | ||||
Testosterone Oenanthate...................... | Castration syndrome (male) | |||
Testosterone Proprionate Injection, B.P. | Klinfelter Reifenstein Albright syndrome | |||
Mammary carcinoma | ||||
Methyltestosterone Tablets, B.P.................. |
| |||
Methyltestosterone, B.P....................... | ||||
Tetanus Antitoxin, B.P. (Bovine)................. | Patients known to be sensitive to horse serum | |||
Tetanus Immune Globulin (Human) | With the written authority of the Director-General, where patients are known to be sensitive to horse serum and cattle serum | |||
| ||||
Tetracosactide............................. | Any disease or condition in a patient receiving treatment in or at an approved hospital | |||
Fifth Schedule—continued
Pharmaceutical Benefits | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act | ||||
Tetracycline Capsules, B.P..................... |
|
| |||
Tetracycline Tablets, B.P...................... | |||||
Tetracycline Injections....................... | A disease or condition specified in this column in relation to Chlortetracycline Capsules except herpes zoster ophthalmicus | ||||
Rolitetracycline............................ | |||||
Tetracycline Hydrochloride Granules, Paediatric Drops and Syrup | |||||
Tetracycline with a buffering agent |
|
| |||
Tetracycline with a buffering agent and Amphotericin B | A disease or condition specified in this column in relation to Oxytetracycline Hydrochloride with a buffering agent and Nystatin | ||||
Tetracycline with a buffering agent and Nystatin | |||||
Thiambutosine Tablets, B.P..................... |
| Hansen’s disease | |||
Thiambutosine Injection...................... | |||||
Thiethylperazine Tablets and Suppositories | With the written authority of the Director-General— | ||||
Radiation sickness | |||||
| Any disease or condition in a pensioner | ||||
Any disease or condition in a patient receiving treatment in or at an approved hospital | |||||
With the written authority of the Director-General— | |||||
Late-stage malignancy | |||||
Radiation sickness | |||||
With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital | |||||
Thioridazine Tablets, B.P...................... | |||||
Thioridazine.............................. | |||||
| |||||
The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride, Thioridazine Hydrochloride, Amitriptyline Hydrochloride, Imipramine Hydrochloride or Nortriptyline Hydrochloride | |||||
Thyrotrophin.............................. | Any disease or condition in a patient receiving treatment in or at an approved hospital | ||||
Tragacanth, Indian (Gum Karaya) | Ileostomy or colostomy conditions | ||||
Trasylol................................. | Any disease or condition in a patient receiving treatment in or at an approved hospital | ||||
Tretamine................................ | Malignant lymphoma and related conditions | ||||
Triamcinolone................................. | With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets | ||||
| Any disease or condition in a pensioner | ||||
Any disease or condition in a patient receiving treatment in or at an approved hospital | |||||
With the written authority of the Director-General— | |||||
Late-stage malignancy | |||||
Radiation sickness | |||||
With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital | |||||
Trifluoperazine Tablets, B.P......................... | |||||
Trifluoperazine Hydrochloride, B.P. | |||||
The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride, Thioridazine Hydrochloride, Amitriptyline Hydrochloride, Imipramine Hydrochloride or, Nortriptyline Hydrochloride | |||||
Fifth Schedule—continued
Pharmaceutical Benefits | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act | |
Trimetaphan Injection, B.P.................. | Hypotensive for anaesthesia | |
Vadrine.............................. | Any disease or condition in a patient receiving treatment in or at an approved hospital | |
Vasopressin Nasal Spray................... | Diabetes insipidus | |
Velactin.............................. | With the written authority of the Director-General— | |
| Galactosaemia | |
| Lactose intolerance | |
| Milk allergy in children under the age of four years | |
Vinblastine Sulphate..................... | Hodgkin’s disease | |
Vincristine Sulphate...................... | Any disease or condition in a patient receiving treatment in or at an approved hospital | |
Viomycin Sulphate...................... |
| Tuberculosis |
Viomycin Sulphate Injection, B.P. | ||
Vitamin A with Aneurine Hydrochloride, Riboflavine, Nicotinamide, Ascorbic Acid and Vitamin D |
| Any disease or condition in a pensioner |
_____________________
By Authority: A. J. Arthur, Commonwealth Government Printer, Canberra